October 22, 2020
Verifiable, a healthcare identity startup that recently launched out of Y Combinator, has raised $3 million in seed funding, TechCrunch reports. The money came from institutional investors Tiger Global, Liquid2 Ventures, Struck Capital and Soma Capital, as well as individual backers Jack Altman, Max Mullen and Sahil Lavingia.
WHAT IT DOES
Verifiable has built an API to help organizations confirm...
September 11, 2020
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health.
COVID-19 has reshaped the way humans interact with technology in...
August 13, 2020
UK-based medtech company MediConnect have announced a new partnership with software specialists Rishabh Software to build a pilot version of their new medical supply chain management platform. The platform will be the first blockchain-based application to manage the supply chain for ordering personal protective equipment (PPE) and medication across multiple health care practices.
WHY IT MATTERS...
June 25, 2020
Cancelled conference data trickles out. Digital respiratory-health company Propeller Health recently shared new study data that were accepted for presentation at the now cancelled Society of Behavioral Medicine 2020 Annual Meeting.
The first of the three abstracts described a sample of 617 adults with asthma or COPD, in which older patients engaged with Propeller's app for longer periods of time...
May 8, 2020
SWISS ARMY TESTS TRACING APP
A COVID-19 contact tracing app is being trialed by 100 soldiers at the Chamblon army base near Lausanne, Switzerland. The Bluetooth-enabled app logs if users have spent more than 15 minutes within two metres of another user. Then, when one uploads a positive test result for COVID-19, the system and alerts users to the contact. In order to test its efficacy, the...
May 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without...
March 29, 2019
A new blockchain-enabled platform aiming to curb doctor’s appointments no-shows with redeemable incentives launched in beta yesterday.
Dubbed Healthereum Life Portfolio, the system will give patients tokens for showing up to appointment, answering surveys and completing other health-related activities. The healthcare provider can specifically create a value for the tokens. Then the tokens can be...
March 25, 2019
Nashville, Tennessee-based Change Healthcare, a health IT company currently owned by a joint venture of McKesson, Blackstone and Hellman & Friedman, has filed to raise $100 million in an upcoming IPO. The company has hired Barclays, Goldman Sachs and JP Morgan as its underwriters, and plans to list its shares on the Nasdaq stock exchange.
In the filing, Change Healthcare wrote that it will...
March 11, 2019
Rally’s new benefits platform. This weekend at SXSW, Rally Health announced the launch of a new digital, consumer-focused wellness platform. The system helps users view, access and manage their employee benefits within a single interface, while offering employers a tool to drive health engagement.
“Today we’re taking our Rally platform to a new level by making traditionally disparate elements of...
Photo by Carsten Koall/Getty Images
February 26, 2019
FDA draft guidance on BCI devices. The FDA signaled its interest in the development of implanted brain-computer interface (BCI) devices on Friday with the release of a new draft guidance focused on the emerging technology. The new document suggests that non-clinical testing of the devices could precede clinical testing as a means to identify and prevent potential risks prior to use by patients.